{"count": 17, "results": [{"_id": "34280626", "pmid": 34280626, "title": "NDMA formation during ozonation of metformin: Roles of ozone and hydroxyl radicals.", "journal": "Sci Total Environ", "authors": ["Liao X", "Shen L", "Jiang Z", "Gao M", "Qiu Y", "Qi H", "Chen C"], "date": "2021-11-20T00:00:00Z", "doi": "10.1016/j.scitotenv.2021.149010", "meta_date_publication": "2021 Nov 20", "meta_volume": "796", "meta_issue": "", "meta_pages": "149010", "score": 50243.965, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a high-consumed pharmaceutical for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, has been reported to generate @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ @CHEMICAL_Dimethylnitrosamine @CHEMICAL_MESH:D004128 @@@nitroso-dimethylamine@@@ (@CHEMICAL_Dimethylnitrosamine @CHEMICAL_MESH:D004128 @@@NDMA@@@) during treatment of its containing wastewater. ", "citations": {"NLM": "Liao X, Shen L, Jiang Z, Gao M, Qiu Y, Qi H, Chen C. NDMA formation during ozonation of metformin: Roles of ozone and hydroxyl radicals. Sci Total Environ. 2021 Nov 20;796():149010. PMID: 34280626", "BibTeX": "@article{34280626, title={NDMA formation during ozonation of metformin: Roles of ozone and hydroxyl radicals.}, author={Liao X and Shen L and Jiang Z and Gao M and Qiu Y and Qi H and Chen C}, journal={Sci Total Environ}, volume={796}, pages={149010}}"}}, {"_id": "38272902", "pmid": 38272902, "pmcid": "PMC10810875", "title": "Preneoplastic cells switch to Warburg metabolism from their inception exposing multiple vulnerabilities for targeted elimination", "journal": "Oncogenesis", "authors": ["Myllymäki H", "Kelly L", "Elliot AM", "Carter RN", "Johansson JA", "Chang KY", "Cholewa-Waclaw J", "Morton NM", "Feng Y"], "date": "2024-01-25T00:00:00Z", "doi": "10.1038/s41389-024-00507-4", "meta_date_publication": "2024 Jan 25", "meta_volume": "13", "meta_issue": "1", "meta_pages": "7", "score": 50243.57, "text_hl": "OXPHOS is impaired in PNCs and complex I inhibitor @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppresses @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@PNC@@@ proliferation and induces @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@PNC@@@ apoptosis in vivo.", "citations": {"NLM": "Myllymäki H, Kelly L, Elliot AM, Carter RN, Johansson JA, Chang KY, Cholewa-Waclaw J, Morton NM, Feng Y. Preneoplastic cells switch to Warburg metabolism from their inception exposing multiple vulnerabilities for targeted elimination Oncogenesis. 2024 Jan 25;13(1):7. PMID: 38272902", "BibTeX": "@article{38272902, title={Preneoplastic cells switch to Warburg metabolism from their inception exposing multiple vulnerabilities for targeted elimination}, author={Myllymäki H and Kelly L and Elliot AM and Carter RN and Johansson JA and Chang KY and Cholewa-Waclaw J and Morton NM and Feng Y}, journal={Oncogenesis}, volume={13}, number={1}, pages={7}}"}}, {"_id": "39350724", "pmid": 39350724, "title": "Metformin represses the carcinogenesis potentially induced by 50 Hz magnetic fields in aged mouse fibroblasts via inhibition of NF-kB.", "journal": "J Cell Mol Med", "authors": ["Soydas T", "Yenmis G", "Tuncdemir M", "Kalkan MT", "Sarac EY", "Bilir A", "Sultuybek GK"], "date": "2024-10-01T00:00:00Z", "doi": "10.1111/jcmm.70132", "meta_date_publication": "2024 Oct", "meta_volume": "28", "meta_issue": "19", "meta_pages": "e70132", "score": 50241.48, "text_hl": "These findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ treatment suppresses the @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ potential of 50 Hz MFs in aged @SPECIES_10090 @@@mouse@@@ fibroblasts, possibly through modulation of NF-kB activation and epithelial-mesenchymal transition modulation.", "citations": {"NLM": "Soydas T, Yenmis G, Tuncdemir M, Kalkan MT, Sarac EY, Bilir A, Sultuybek GK. Metformin represses the carcinogenesis potentially induced by 50 Hz magnetic fields in aged mouse fibroblasts via inhibition of NF-kB. J Cell Mol Med. 2024 Oct;28(19):e70132. PMID: 39350724", "BibTeX": "@article{39350724, title={Metformin represses the carcinogenesis potentially induced by 50 Hz magnetic fields in aged mouse fibroblasts via inhibition of NF-kB.}, author={Soydas T and Yenmis G and Tuncdemir M and Kalkan MT and Sarac EY and Bilir A and Sultuybek GK}, journal={J Cell Mol Med}, volume={28}, number={19}, pages={e70132}}"}}, {"_id": "39519030", "pmid": 39519030, "title": "Li-Fraumeni Syndrome: Narrative Review Through a Case Report with Ten Years of Primary Tumor Remission Associated with Sechium H387 07 Supplementation.", "journal": "Int J Mol Sci", "authors": ["Amador-Gómez AI", "Aguiñiga-Sánchez I", "Mendoza-Núñez VM", "Cadena-Iñiguez J", "Romero-López E", "Santiago-Osorio E"], "date": "2024-10-25T00:00:00Z", "doi": "10.3390/ijms252111477", "meta_date_publication": "2024 Oct 25", "meta_volume": "25", "meta_issue": "21", "meta_pages": "", "score": 50235.848, "text_hl": "Recently, protocols involving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a prophylactic medication have been developed to target @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@precancerous@@@ niches. ", "citations": {"NLM": "Amador-Gómez AI, Aguiñiga-Sánchez I, Mendoza-Núñez VM, Cadena-Iñiguez J, Romero-López E, Santiago-Osorio E. Li-Fraumeni Syndrome: Narrative Review Through a Case Report with Ten Years of Primary Tumor Remission Associated with Sechium H387 07 Supplementation. Int J Mol Sci. 2024 Oct 25;25(21):. PMID: 39519030", "BibTeX": "@article{39519030, title={Li-Fraumeni Syndrome: Narrative Review Through a Case Report with Ten Years of Primary Tumor Remission Associated with Sechium H387 07 Supplementation.}, author={Amador-Gómez AI and Aguiñiga-Sánchez I and Mendoza-Núñez VM and Cadena-Iñiguez J and Romero-López E and Santiago-Osorio E}, journal={Int J Mol Sci}, volume={25}, number={21}}"}}, {"_id": "35203540", "pmid": 35203540, "pmcid": "PMC8869656", "title": "Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities", "journal": "Biomedicines", "authors": ["Kanwal A", "Kanwar N", "Bharati S", "Srivastava P", "Singh SP", "Amar S"], "date": "2022-01-31T00:00:00Z", "doi": "10.3390/biomedicines10020331", "meta_date_publication": "2022 Jan 31", "meta_volume": "10", "meta_issue": "2", "meta_pages": "", "score": 50233.145, "text_hl": "Nevertheless, troubling developments and fresh challenges are still evident. Recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, the most widely used first-line drug for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, was found to contain a @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ contaminant known as @CHEMICAL_Dimethylnitrosamine @CHEMICAL_MESH:D004128 @@@N-nitroso dimethylamine@@@ (@CHEMICAL_Dimethylnitrosamine @CHEMICAL_MESH:D004128 @@@NDMA@@@). ", "citations": {"NLM": "Kanwal A, Kanwar N, Bharati S, Srivastava P, Singh SP, Amar S. Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities Biomedicines. 2022 Jan 31;10(2):. PMID: 35203540", "BibTeX": "@article{35203540, title={Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities}, author={Kanwal A and Kanwar N and Bharati S and Srivastava P and Singh SP and Amar S}, journal={Biomedicines}, volume={10}, number={2}}"}}, {"_id": "33368407", "pmid": 33368407, "title": "Application of capillary electrophoresis-nano-electrospray ionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals.", "journal": "Electrophoresis", "authors": ["Řemínek R", "Foret F", "Chung DS"], "date": "2021-02-01T00:00:00Z", "doi": "10.1002/elps.202000303", "meta_date_publication": "2021 Feb", "meta_volume": "42", "meta_issue": "4", "meta_pages": "334-341", "score": 50233.113, "text_hl": "After a presence of highly hepatotoxic and potentially @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ @CHEMICAL_Dimethylnitrosamine @CHEMICAL_MESH:D004128 @@@N-nitrosodimethylamine@@@ was detected in certain lots of sartan, @CHEMICAL_Ranitidine @CHEMICAL_MESH:D011899 @@@ranitidine@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and other pharmaceuticals, local regulatory authorities issued recalls of suspected products, and concerns of the pharmacotherapy safety were widely discussed. ", "citations": {"NLM": "Řemínek R, Foret F, Chung DS. Application of capillary electrophoresis-nano-electrospray ionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals. Electrophoresis. 2021 Feb;42(4):334-341. PMID: 33368407", "BibTeX": "@article{33368407, title={Application of capillary electrophoresis-nano-electrospray ionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals.}, author={Řemínek R and Foret F and Chung DS}, journal={Electrophoresis}, volume={42}, number={4}, pages={334-341}}"}}, {"_id": "28373897", "pmid": 28373897, "pmcid": "PMC5376285", "title": "New insight for metformin against bladder cancer", "journal": "Genes Environ", "authors": ["El-Arabey AA"], "date": "2017-04-01T00:00:00Z", "doi": "10.1186/s41021-017-0074-z", "meta_date_publication": "2017", "meta_volume": "39", "meta_issue": "", "meta_pages": "13", "score": 50065.99, "text_hl": "...Anti-@<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@", "citations": {"NLM": "El-Arabey AA. New insight for metformin against bladder cancer Genes Environ. 2017;39():13. PMID: 28373897", "BibTeX": "@article{28373897, title={New insight for metformin against bladder cancer}, author={El-Arabey AA}, journal={Genes Environ}, volume={39}, pages={13}}"}}, {"_id": "21924289", "pmid": 21924289, "title": "Metformin and neoplasia: implications and indications.", "journal": "Pharmacol Ther", "authors": ["Aljada A", "Mousa SA"], "date": "2012-01-01T00:00:00Z", "doi": "10.1016/j.pharmthera.2011.09.004", "meta_date_publication": "2012 Jan", "meta_volume": "133", "meta_issue": "1", "meta_pages": "108-15", "score": 50057.617, "text_hl": "This review article discusses the epidemiological studies and examines the possible mechanisms by which @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exerts its anti-@<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@carcinogenic@@@ activities in @DISEASE_Ovarian_Neoplasms @DISEASE_MESH:D010051 @@@breast, colon, ovarian, lung, and prostate cancers@@@. ", "citations": {"NLM": "Aljada A, Mousa SA. Metformin and neoplasia: implications and indications. Pharmacol Ther. 2012 Jan;133(1):108-15. PMID: 21924289", "BibTeX": "@article{21924289, title={Metformin and neoplasia: implications and indications.}, author={Aljada A and Mousa SA}, journal={Pharmacol Ther}, volume={133}, number={1}, pages={108-15}}"}}, {"_id": "24683044", "pmid": 24683044, "pmcid": "PMC4101764", "title": "Modulation by metformin of molecular and histopathological alterations in the lung of cigarette smoke-exposed mice", "journal": "Cancer Med", "authors": ["Izzotti A", "Balansky R", "D'Agostini F", "Longobardi M", "Cartiglia C", "Micale RT", "La Maestra S", "Camoirano A", "Ganchev G", "Iltcheva M", "Steele VE", "De Flora S"], "date": "2014-06-01T00:00:00Z", "doi": "10.1002/cam4.234", "meta_date_publication": "2014 Jun", "meta_volume": "3", "meta_issue": "3", "meta_pages": "719-30", "score": 50056.727, "text_hl": "In conclusion, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was able to protect the @SPECIES_10090 @@@mouse@@@ lung from smoke-induced @DISEASE_DNA_Virus_Infections @DISEASE_MESH:D004266 @@@DNA@@@ and microRNA alterations and to inhibit @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@preneoplastic lesions@@@ in lung and @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney@@@ but failed to prevent @DISEASE_Lung_Diseases @DISEASE_MESH:D008171 @@@lung adenomas@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@malignant tumors@@@ induced by this complex mixture.", "citations": {"NLM": "Izzotti A, Balansky R, D'Agostini F, Longobardi M, Cartiglia C, Micale RT, La Maestra S, Camoirano A, Ganchev G, Iltcheva M, Steele VE, De Flora S. Modulation by metformin of molecular and histopathological alterations in the lung of cigarette smoke-exposed mice Cancer Med. 2014 Jun;3(3):719-30. PMID: 24683044", "BibTeX": "@article{24683044, title={Modulation by metformin of molecular and histopathological alterations in the lung of cigarette smoke-exposed mice}, author={Izzotti A and Balansky R and D'Agostini F and Longobardi M and Cartiglia C and Micale RT and La Maestra S and Camoirano A and Ganchev G and Iltcheva M and Steele VE and De Flora S}, journal={Cancer Med}, volume={3}, number={3}, pages={719-30}}"}}, {"_id": "26245871", "pmid": 26245871, "pmcid": "PMC4553001", "title": "Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways", "journal": "J Exp Clin Cancer Res", "authors": ["Pan Q", "Yang GL", "Yang JH", "Lin SL", "Liu N", "Liu SS", "Liu MY", "Zhang LH", "Huang YR", "Shen RL", "Liu Q", "Gao JX", "Bo JJ"], "date": "2015-08-07T00:00:00Z", "doi": "10.1186/s13046-015-0183-0", "meta_date_publication": "2015 Aug 7", "meta_volume": "34", "meta_issue": "1", "meta_pages": "77", "score": 50056.277, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can block @<m>DISEASE_Precancerous_Conditions</m> @DISEASE_MESH:D011230 @@@precancerous@@@ progression to invasive @DISEASE_Urinary_Bladder_Neoplasms @DISEASE_MESH:D001749 @@@tumors of bladder@@@ through inhibiting @GENE_STAT3 @GENE_6774 @@@STAT3@@@-mediated signaling pathways", "citations": {"NLM": "Pan Q, Yang GL, Yang JH, Lin SL, Liu N, Liu SS, Liu MY, Zhang LH, Huang YR, Shen RL, Liu Q, Gao JX, Bo JJ. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways J Exp Clin Cancer Res. 2015 Aug 7;34(1):77. PMID: 26245871", "BibTeX": "@article{26245871, title={Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways}, author={Pan Q and Yang GL and Yang JH and Lin SL and Liu N and Liu SS and Liu MY and Zhang LH and Huang YR and Shen RL and Liu Q and Gao JX and Bo JJ}, journal={J Exp Clin Cancer Res}, volume={34}, number={1}, pages={77}}"}}]}